| |
1 Month |
3 Month |
6 Month |
YTD |
1 Year |
3 Year |
5 Year |
10 Year |
Since
Fund
Inception |
|
Fund Performance
|
| Net Asset Value (NAV) |
2.87% |
5.99% |
19.93% |
16.22% |
26.93% |
6.61% |
6.62% |
6.46% |
6.71% |
|
Index Performance
|
| NYSE® Arca® Biotechnology Index |
3.37% |
6.00% |
20.13% |
17.60% |
27.72% |
7.34% |
5.10% |
8.21% |
8.88% |
| Nasdaq Biotechnology™ Index |
0.52% |
-1.19% |
8.68% |
13.47% |
24.55% |
2.77% |
6.24% |
6.62% |
7.30% |
| S&P Composite 1500® Health Care Index |
1.24% |
-2.10% |
6.55% |
16.16% |
18.19% |
8.66% |
10.98% |
12.02% |
12.81% |
| S&P 500® Index |
6.34% |
11.32% |
18.20% |
35.99% |
38.27% |
14.74% |
16.99% |
15.70% |
16.33% |
Inception Date: 2014-10-29
Effective February 17, 2021, the First Trust ETF changed its investment objectives to seek to replicate, to the extent possible, the performance of an index of U.S. companies in the biotechnology industry, initially the NYSE Arca Biotechnology IndexSM. The First Trust ETF provides exposure to its new index by investing all or substantially all of its assets in an underlying U.S. index fund known as First Trust NYSE Arca Biotechnology Index Fund, which is managed by the First Trust ETF's portfolio advisor. If this change had been effective throughout the performance measurement period the performance of the First Trust ETF should have more closely replicated performance of the index.
Commissions, management fees and expenses all may be associated with investing in the funds. Please read the prospectus before investing. The indicated rates of return, over one year, are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. The funds are not guaranteed, their values change frequently and past performance may not be repeated.